Search for: "TRANS DIGITAL TECHNOLOGIES, LLC v. USA" Results 1 - 6 of 6
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Dec 2016, 4:30 am by Ben
2016 - it's been another frantic copyright year - and buzz words and themes for the twelve months included 'the value gap' between the content industries and the technology giants, linking, that 'new public', fair use, 'transformative' art, and the ongoing reform of copyright laws - in Europe, and in particular reforms to the Digital Millennium Copyright Act in the USA. [read post]
28 Dec 2015, 2:51 am by Ben
 WikiLeaks released  the "Investment Chapter" from the secret negotiations for the TPP (Trans-Pacific Partnership) agreement. [read post]
25 Oct 2008, 12:18 am
Swisa: implications for India (Spicy IP) Centre for Science and Environment accused of copyright infringement by Mint's editor (Spicy IP) Delhi High Court dicta on fair dealing increases woes of news channels: ESPN Stars Sports v. [read post]
30 Dec 2018, 3:03 am by Ben
Indeed safe harbour was the focus of endless debate, and the reforms in Europe were perhaps the most talked about and the most fiercely debated, but moves to prod copyright into the digital age were also taking place in Japan, South Africa, Australia and New Zealand to name but a few, and China went one step further, bringing in three 'internet courts' fit for intellectual property law in the digital age with the availability of blockchain technology to… [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva… [read post]